Home
Journal Issues
Current Issue
All Issues
In Progress
Contact Us
Create Account
Login
Title
Abstract
Full Text
Keywords
Author
First Name
Last Name
Search
eISSN
:
3080-0382
Biomed adv
. 2025;2(3): 131-136. doi:
10.34172/bma.26
Review Article
New developments in epigenetic and genetic biomarkers for differentiated thyroid cancer (DTC): Moving toward accurate diagnosis and treatment by 2025
Samaneh Hosseinzadeh
, Safura Pakizehkar, Hoda Golab-Ghadaksaz, Laleh Hoghooghi Rad, Mehdi Hedayati *
Cited by CrossRef: 0
Submit Your Paper
Editorial Board
Editorial Policies
Aims and Scope
For Authors
Archive
Acceptance Rate:
35%
Submission to First Decision:
20 Days
Received to Acceptance:
60 Days
Acceptance to Publication:
40 Days
*
Average article statistics from the last 12 months of data.
In
collaboration with